Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 23.82 BATS BZX Real-Time Price As of 1:58pm ET |  +0.86 / +3.75%Today’s Change | 14.21 Today|||52-Week Range 37.75 | +40.45% Year-to-Date |
Institutional investors purchased a net $1.7 million shares of ARCT during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 89.94% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
| Mutual fund holders | 62.51% |
| Other institutional | 27.43% |
| Individual stakeholders | 14.22% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 9/30/2023 | GRANAHAN INVESTMENT MANAGEMENT, ... Bought 398.9 Thousand shares of Arcturus Therapeutics Hol... |
| 9/30/2023 | MORGAN STANLEY & CO. LLC Bought 360.4 Thousand shares of Arcturus Therapeutics Hol... |
| 9/30/2023 | POINT72 ASSET MANAGEMENT LP Bought 311.0 Thousand shares of Arcturus Therapeutics Hol... |
Top 10 Owners of Arcturus Therapeutics Holdings Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Federated Global Investment Manag... | 17.71% | 4,711,512 | 89,989,879 | -66,988 | -1.40% |
| ARK Investment Management LLC | 7.15% | 1,901,546 | 36,319,529 | -5,450 | -0.29% |
| BlackRock Fund Advisors | 6.53% | 1,737,898 | 33,193,852 | +23,014 | +1.34% |
| SSgA Funds Management, Inc. | 6.27% | 1,667,925 | 31,857,368 | -316,243 | -15.94% |
| Nikko Asset Management Americas, ... | 5.22% | 1,388,574 | 26,521,763 | -16,358 | -1.16% |
| The Vanguard Group, Inc. | 5.14% | 1,366,258 | 26,095,528 | -221,483 | -13.95% |
| Woodline Partners LP | 4.02% | 1,069,814 | 20,433,447 | 0 | 0.00% |
| Dimensional Fund Advisors LP | 3.66% | 973,843 | 18,600,401 | +278,989 | +40.15% |
| Fidelity Management & Research Co... | 3.54% | 940,281 | 17,959,367 | +74,083 | +8.55% |
| Morgan Stanley & Co. LLC | 2.08% | 552,549 | 10,553,686 | +360,357 | +187.50% |
Top 10 Mutual Funds Holding Arcturus Therapeutics Holdings Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Federated Hermes Kaufmann Fund | 9.22% | 2,451,016 | 46,814,406 | -23,984 | -0.97% |
| Federated Hermes Kaufmann Small C... | 8.26% | 2,198,020 | 41,982,182 | -31,980 | -1.43% |
| ARK Genomic Revolution ETF | 6.96% | 1,852,356 | 35,380,000 | -8,976 | -0.48% |
| Nikko AM Global Umbrella Fund - A... | 4.61% | 1,227,259 | 23,440,647 | -37,077 | -2.93% |
| SPDR S&P Biotech ETF | 4.33% | 1,151,016 | 21,984,406 | +6,878 | +0.60% |
| Fidelity Select Port. - Biotechno... | 3.40% | 904,630 | 17,278,433 | 0 | 0.00% |
| Vanguard Total Stock Market ETF | 2.70% | 716,967 | 13,694,070 | 0 | 0.00% |
| iShares Russell 2000 ETF | 2.03% | 539,573 | 10,305,844 | -5,428 | -1.00% |
| Vanguard Extended Market Index Fu... | 1.32% | 350,579 | 6,696,059 | +6,393 | +1.86% |
| JPMorgan Funds - Thematics - Gene... | 1.24% | 328,567 | 6,275,630 | +17,129 | +5.50% |